Analysts expect K2M Group Holdings (NASDAQ:KTWO) to post ($0.22) earnings per share for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for K2M Group’s earnings. The highest EPS estimate is ($0.19) and the lowest is ($0.24). K2M Group posted earnings per share of ($0.26) during the same quarter last year, which would indicate a positive year-over-year growth rate of 15.4%. The company is scheduled to announce its next earnings results after the market closes on Tuesday, May 1st.
According to Zacks, analysts expect that K2M Group will report full-year earnings of ($0.73) per share for the current fiscal year, with EPS estimates ranging from ($0.75) to ($0.70). For the next financial year, analysts forecast that the firm will report earnings of ($0.50) per share, with EPS estimates ranging from ($0.57) to ($0.43). Zacks’ earnings per share averages are a mean average based on a survey of sell-side research firms that cover K2M Group.
K2M Group (NASDAQ:KTWO) last released its earnings results on Wednesday, February 28th. The medical device company reported ($0.20) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.19) by ($0.01). The company had revenue of $67.80 million for the quarter, compared to analysts’ expectations of $67.36 million. K2M Group had a negative net margin of 14.40% and a negative return on equity of 14.85%. K2M Group’s revenue for the quarter was up 9.7% on a year-over-year basis. During the same quarter last year, the firm posted ($0.30) earnings per share.
KTWO has been the topic of several analyst reports. Barclays reiterated a “buy” rating and set a $25.00 target price on shares of K2M Group in a research report on Tuesday, January 9th. Needham & Company LLC lifted their target price on K2M Group from $20.00 to $23.00 and gave the company a “buy” rating in a research report on Tuesday, January 9th. BidaskClub upgraded K2M Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 10th. Oppenheimer set a $24.00 target price on K2M Group and gave the company a “buy” rating in a research report on Thursday, March 1st. Finally, Zacks Investment Research upgraded K2M Group from a “sell” rating to a “hold” rating in a research report on Thursday, January 25th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and nine have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $24.50.
NASDAQ KTWO traded up $0.07 on Monday, hitting $19.44. 93,122 shares of the company traded hands, compared to its average volume of 271,800. The company has a market capitalization of $840.42, a PE ratio of -22.29 and a beta of 1.47. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.52 and a current ratio of 2.84. K2M Group has a 52-week low of $16.44 and a 52-week high of $25.99.
A number of large investors have recently bought and sold shares of the business. MetLife Investment Advisors LLC bought a new stake in K2M Group during the fourth quarter valued at about $350,000. Two Sigma Investments LP raised its holdings in K2M Group by 35.7% during the fourth quarter. Two Sigma Investments LP now owns 201,918 shares of the medical device company’s stock valued at $3,635,000 after acquiring an additional 53,126 shares during the period. Folger Hill Asset Management LP bought a new stake in K2M Group during the fourth quarter valued at about $1,080,000. TimesSquare Capital Management LLC raised its holdings in K2M Group by 1.6% during the fourth quarter. TimesSquare Capital Management LLC now owns 2,532,675 shares of the medical device company’s stock valued at $45,588,000 after acquiring an additional 38,715 shares during the period. Finally, Sectoral Asset Management Inc raised its holdings in K2M Group by 29.9% during the fourth quarter. Sectoral Asset Management Inc now owns 1,164,412 shares of the medical device company’s stock valued at $20,959,000 after acquiring an additional 267,698 shares during the period. 98.65% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: “Zacks: Brokerages Anticipate K2M Group Holdings (KTWO) Will Announce Earnings of -$0.22 Per Share” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/23/zacks-brokerages-anticipate-k2m-group-holdings-ktwo-will-announce-earnings-of-0-22-per-share.html.
K2M Group Company Profile
K2M Group Holdings, Inc, a medical device company, provides spine and minimally invasive solutions in the United States and internationally. The company offers implants, disposables, and instruments primarily to hospitals for use by spine surgeons to treat spinal pathologies, such as deformity, trauma, and tumor.
Get a free copy of the Zacks research report on K2M Group (KTWO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.